DOSSIER · 13F-HR · Q1 2026

DRIEHAUS CAPITAL MANAGEMENT LLC

$13.6B in tracked AUM across 356 positions as of Q1 2026.

DC
CIK 0000938206 · last filed Mar 31, 2026
Total AUM
$13.6B
as of Q1 2026
Holdings
356
positions
Whale Score
57
57
tracked
Activity
no data
changes this Q
AI Analysis · Q1 2026

DRIEHAUS CAPITAL MANAGEMENT LLC reported $13.6B in 13F holdings for the quarter ending 2026-03-31, concentrated in unknown with leading positions in TSM, PRAX, XENE. Notable moves this quarter: G3323L INCREASED (+$94.2M); EOSE INCREASED ($-89.8M). 18 new positions initiated, 18 closed out, reflecting 68 total changes from the prior quarter.

DRIEHAUS CAPITAL MANAGEMENT LLC entered 2026-03-31 with $13.6B in reported 13F holdings, placing it among the institution's recent AUM range. The portfolio maintains a unknown tilt, with the top five positions accounting for a meaningful share of the overall book.

Top Holdings

Analysis generated by 13F Insight from SEC Form 13F filing data · Q1 2026. Methodology

Quarter at a glance — Q1 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q1 2026.

#HoldingValueSharesWeight
01
TSM
TSMC
$427M1.3M3.1%
02
PRAX
Praxis Precision Medicines Inc
$306M949K2.2%
03
XENE
Xenon Pharmaceuticals Inc
$261M4.5M1.9%
04
CRNX
Crinetics Pharmaceuticals Inc
$232M6.4M1.7%
05
PL
Planet Labs PBC
$221M7.9M1.6%
06
G3323L100
Fabrinet
$204M391K1.5%
07
APGE
Apogee Therapeutics Inc
$162M1.9M1.2%
08
LITE
Lumentum Holdings Inc
$161M229K1.2%
09
CW
Curtiss-Wright Corp
$154M226K1.1%
10
G2519Y108
Credicorp Ltd
$153M451K1.1%

Filing history

2026Q1Mar 31
$13.6B 7.6%
356 positionsView →
2025Q4Dec 31
$14.7B 69.8%
404 positionsView →
2025Q3Sep 30
$8.7B 8.3%
282 positionsView →
2025Q2Jun 30
$8.0B 19.1%
272 positionsLocked
2025Q1Mar 31
$6.7B 44.5%
253 positionsLocked
2024Q4Dec 31
$12.1B 4.0%
381 positionsLocked
2024Q3Sep 30
$11.6B 12.7%
375 positionsLocked
2024Q2Jun 30
$10.3B 3.0%
361 positionsLocked
2024Q1Mar 31
$10.0B 20.9%
380 positionsLocked
2023Q4Dec 31
$8.3B 7.9%
379 positionsLocked
2023Q3Sep 30
$7.7B 2.9%
390 positionsLocked
2023Q2Jun 30
$7.9B 11.2%
380 positionsLocked
Showing 12 of 97